M.D. MAIA’s poster will be available on the Publications page of MAIA’s website on the day of the presentation. The 2025 ASCO Annual Meeting will feature over 200 sessions and more than 5,000 ...

MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an abstract about the efficacy data from the Phase 2 THIO-101 clinical ...